Guardian Pharmacy
GRDN
Guardian Pharmacy (GRDN) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Maintained | Outperform | $49.00 from $43.00 | Aug 7, 2026 |
| B of A Securities | Maintained | Buy | $47.00 from $42.00 | Jun 17, 2026 |
| Truist Securities | Maintained | Buy | $47.00 from $43.00 | Jun 17, 2026 |
| Oppenheimer | Maintained | Outperform | $43.00 from $38.00 | May 7, 2026 |
| B of A Securities | Initiated Coverage | Buy | $42.00 | Apr 27, 2026 |
| Truist Securities | Maintained | Buy | $43.00 from $38.00 | Apr 13, 2026 |
| Jefferies | Initiated Coverage | Buy | $44.00 | Mar 30, 2026 |
| Truist Securities | Maintained | Buy | $38.00 from $34.00 | Mar 12, 2026 |
| Oppenheimer | Maintained | Outperform | $38.00 from $35.00 | Mar 12, 2026 |
| Stephens & Co. | Maintained | Overweight | $36.00 from $35.00 | Jan 14, 2026 |
| Truist Securities | Maintained | Buy | $34.00 from $30.00 | Nov 14, 2025 |
| Oppenheimer | Initiated Coverage | Outperform | $30.00 | Oct 10, 2025 |
| Truist Securities | Maintained | Buy | $30.00 from $28.00 | Sep 26, 2025 |
| Truist Securities | Maintained | Buy | $28.00 from $25.00 | May 19, 2025 |
| Truist Securities | Maintained | Buy | $25.00 from $24.00 | Apr 11, 2025 |
| Truist Securities | Maintained | Buy | $24.00 from $22.00 | Nov 15, 2024 |
| Stephens & Co. | Initiated Coverage | Overweight | $21.00 | Oct 22, 2024 |
| Truist Securities | Initiated Coverage | Buy | $22.00 | Oct 21, 2024 |
Frequently asked questions
What is the latest analyst rating on GRDN?
On Aug 7, 2026, Oppenheimer maintained Guardian Pharmacy at Outperform with a price target of $49.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.